Member Info for Energyshares

Avacta read Rah’s tweet last night given another hint.
:):):)

Pharma3
Thanks for your kind words
I’m just taking my allocation which is guaranteed. TBH I’m over exposed so don’t need any more. Good luck to anyone trying for more.
This boards knowledge has helped me build my position.
GLA in the next few weeks.

If the SP had stayed around the late 90’s
Some might of not taken their allocation,
But with a 20% rise now and probably more to come next week.
Everyone will be taking their allocation.

GLA

Another great watch only 4 mins.
AS if AVA6000 works could be applied to any chemotherapy.
That’s some market to go at…

https://m.youtube.com/watch?v=79nKnzvJB98

GLA sit tight…

A working AVA6000 unlocks the platform and also unlocks TMac.
3 years ago ADC went into partnership with Avacta on a affimer cancer drug and later pulled out of the deal.

Next week someone at ADC could be getting the sack.

https://m.youtube.com/watch?v=fPr3jSFb64o

“How pathetic. All this squabbling about how much the company is worth by people who know nothing about valuing biopharma companies”

Mr A yesterday

“GSK MCap of £56.22bn, AZ £153.06bn, so yes, easily £50 per share.”

“As I said, £40 per share would get my interest.”

Big Al you are my 7:00am
Alarm clock

Any one of these babies could land.

AVA6000 PK Data

Science day date revealed

AVA3996 licence

Biopsies results

TMac update

LG Chem (IND) date

1b Start date

US trial sites announced

All 6 UK sites recruiting

Affidx Diagnostic Re-launch

Another Diagnostic company acquisition

New Diagnostic announced

Nasdaq Listing

Affyxell update

Point Bio licence payment

Biokit royalties from affimer IVD) product.

Royalties from Astrea Bioseparations first affimer product.

And the Big one
Take over approach

GLA

After PK data is released it could show Precision works.
Then Avacta have a platform of over a dozen drugs to throw at the market in licensing deals or they may keep a few in house.
But this also unlocks another mega value platform in TMac.

It’s like building and releasing a Escort but they are working on a Rolls Royce to follow.

GLA keep hold of your golden wonka tickets.

TMAC® Technology
Incorporating pre|CISIONTM technology in the
linker of Affimer-drug conjugates ensures localised, extracellular release of a chemotoxin payload in the tumour microenvironment. This mechanism overcomes the need to target an internalising cancer marker, as with conventional drug conjugates, allowing the Affimer® to be selected to target an immune checkpoint. Thus, the innate immune response to the chemotoxin is supported by the Affimer® immune checkpoint blockade in
this novel class of checkpoint targeting tumour microenvironment activated drug conjugates (TMAC®).

Why would Avacta pay for biopsies if they knew AVA6000 was not activating at the tumour.

This now proves Precision works and when that little affimer is added to precision as a warhead the tumour doesn’t stand a chance. TMac ready steady Go…….

I found it on Natalie Cook twitter page she is the lead on the AVA6K trial at the Christie.
GLA

November looking good.

Wed, 23 November 2022, 14:00 – 15:30 GMT
Online
Manchester Christie oncology school

State of the art precision medicine trials in the UK

https://www.eventbrite.co.uk/e/precision-medicine-in-oncology-tickets-423248195747

https://m.youtube.com/watch?v=9-gZH1KPPuI

Roses are Red
Rippers a Blue
You fight off the trolls
But your team is poo.

Couldn’t resist :)

Don’t bite rippers

Thanks

If your fully max up in your ISA
Does anyone know if you can buy the open offer into the ISA ?

If a T/O arrives from Big Pharma after great PK data for AVA6000 and one of the Big boys decides to take Avacta Therapeutics out.

Where does it leave Big Al and the board.

They will not be offered a place on a major Pharma’s board.

Big Al’s baby is Affimers and if he can move across to be Boss of Avacta Diagnostics with millions in his A rse pocket and still get to see his baby affimers perform each day, I think he would be happy.

Have they got a offer on the table for the therapeutic division and yesterday’s building up of the diagnostic division was Big Al’s and the boards route for another chance of control of affimers.

Just a thought….

GLA

Clowns

Here they go hash tagging The Death Spiral :):):)

He calls this a failing business :

“Launch Diagnostics is a leading independent IVD distributor in the UK with over 30 years' track record, with its headquarters in Kent and around 70 staff. It provides immunodiagnostic and molecular test products, technical support and maintenance to healthcare providers. Launch Diagnostics serves private and public sector customers throughout the UK, France, Belgium, Luxembourg and Republic of Ireland, with c. 95% repeat business.”

Episcopus
The #AVCT death spiral is here
Whopping £50mil taken out and will be sold onto the market as shares
Also bought a failing testing business for good measure.

Let’s watch them burn……

SP finished level after slight dilution.
Secured £62 million in funding.
Trial funding until end of 2024.
Bought a diagnostic company that had no debt and recurring income.
Wetherby employees returned to work.

Trolls missing in action TW called emergency meeting came up with new catchphrase Death Spiral
:):):):):)

If I had access to AVA6000 PK data and seen it works,I would be buying shares at every legal opportunity I could.

Dr Eliot Forster, has subscribed for 15,000 new Ordinary Shares at the Offer Price (the "Management Subscription Shares" and the "Management Subscription", respectively) pursuant to a subscription letter entered into with the Company.